Sonoma Pharmaceuticals Inc. (SNOA)
NASDAQ · Healthcare
Sonoma Pharmaceuticals Inc. Shareholder Equity 2011–2025
Sonoma Pharmaceuticals Inc. annual shareholder equity history from 2011 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Sonoma Pharmaceuticals Inc. shareholder equity as of March 31, 2025: 4.4M, a 28.12% decrease year-over-year.
- Sonoma Pharmaceuticals Inc. shareholder equity for 2025 were 4.4M, a 28.12% decrease from 2024.
- Sonoma Pharmaceuticals Inc. shareholder equity for 2024 were 6.1M, a 23.07% decrease from 2023.
- Sonoma Pharmaceuticals Inc. shareholder equity for 2023 were 8.0M, a 8.28% decrease from 2022.
- Sonoma Pharmaceuticals Inc. shareholder equity for 2022 were 8.7M.
Shareholder Equity
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Sonoma Pharmaceuticals Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $4 |
| 2024 | $6 |
| 2023 | $8 |
| 2022 | $9 |
| 2021 | $5 |
| 2020 | $6 |
| 2019 | $8 |
| 2018 | $15 |
| 2017 | $21 |
| 2016 | $10 |
| 2015 | $12 |
| 2014 | $12 |
| 2013 | $4 |
| 2012 | $-1 |
| 2011 | $2 |
Sonoma Pharmaceuticals Inc. Shareholder Equity — FAQ
Sonoma Pharmaceuticals Inc. (SNOA) shareholder equity over the last 15 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see SNOA's shareholder equity history?
The chart and table above show Sonoma Pharmaceuticals Inc.'s shareholder equity by year and by quarter, including the growth rate.